Bill C-265 was debated
Bill C-265, An Act to amend the Food and Drugs Act (List of Therapeutic Products Pre-approved for Special Access), was debated at second reading.
Bill C-265, An Act to amend the Food and Drugs Act (List of Therapeutic Products Pre-approved for Special Access), was debated at second reading.
Bill C-230, An Act to amend the Financial Administration Act and to make consequential amendments to other Acts (debt forgiveness registry), was concurred in at report stage. The Bill was debated at third reading and adopted at third reading.
Bill C-11, Military Justice System Modernization Act, may be debated at third reading.
The Standing Committee on Foreign Affairs and International Development eighth report, A War on Civilians: Addressing the Human Toll of the Conflict in Sudan.
The Standing Committee on Procedure and House Affairs presented two reports: Report 26 – Main Estimates 2026-27: Vote 1 under House of Commons, Vote 1 under Leaders’ Debates Commission, Vote 1 under Office of the Chief Electoral Officer and Vote 1 under Parliamentary Protective Service Report 27 – Changes to Membership of Standing and Standing Joint … Read more
Bill C-263, An Act to establish a national framework for silver alerts, was debated at second reading.